Pulmidone 267 mg (Tablet)
Unit Price: ৳ 45.00 (2 x 10: ৳ 900.00)
Strip Price: ৳ 450.00
Medicine Details
Category | Details |
---|---|
Generic | Pirfenidone |
Company | Beximco pharmaceuticals ltd |
Also available as |
Indications
- Treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF) in adults
Pharmacology
- Anti-inflammatory
- Antioxidant
- Anti-fibrotic properties
- Improves lung function
- Reduces acute exacerbations in IPF patients
- Suppresses TGF-β1
- Downregulates pro-inflammatory cytokines
- Inhibits inflammatory cell influx
- Reduces pulmonary vascular permeability induced by bleomycin
Dosage & Administration
- Oral route of administration
- Recommended daily dose titration
- Dose adjustment for gastrointestinal events
- Dose adjustment for photosensitivity reactions or rash
- Dose adjustment for hepatic function
- Re-initiation of therapy after treatment interruption
- Resumption of dose after interruption of less than 14 days
- Instructions for use with food
Interactions
- Interactions with moderate and strong CYP1A2 inhibitors
- Dosage adjustments with ciprofloxacin use
- Different adverse reaction incidence observed in fed vs. fasted state
Contraindications
- Hypersensitivity to active substance or excipients
- Concomitant use of fluvoxamine
- Severe hepatic impairment or end-stage liver disease
- Severe renal impairment (CrCl <30 ml/min) or end-stage renal disease requiring dialysis
Side Effects
- Common: nausea, rash, abdominal pain, upper respiratory tract infection, diarrhea, fatigue, headache, dyspepsia, dizziness, vomiting, anorexia, gastroesophageal reflux disease, sinusitis, insomnia, weight decrease, arthralgia
- Rare: photosensitivity reaction, decreased appetite, pruritus, asthenia, dysgeusia, non-cardiac chest pain
Pregnancy & Lactation
- Precautionary avoidance during pregnancy
- Unknown excretion in human milk
- Effects on fertility and reproductive performance in rats
Precautions & Warnings
- Monitoring and dosage modifications for elevated liver enzymes
- Monitoring and dosage modifications for photosensitivity and rash
- Monitoring and dosage modifications for gastrointestinal disorders
- Use in special populations: children & adolescents, hepatic impairment, renal impairment, smokers
Use in Special Populations
- Safety and efficacy in children & adolescents not established
- Monitoring and dosage modifications for hepatic impairment
- Monitoring and dosage modifications for renal impairment
- Altered exposure in smokers
Overdose Effects
- Limited clinical experience with overdose
- Mild, transient adverse reactions
Therapeutic Class
- Immunosuppressant
Storage Conditions
- Cool and dry storage
- Protection from light and moisture
- Keep out of reach of children
Related Brands
- Pulmosis 267 mg (Capsule) - incepta-pharmaceuticals-ltd
- Pulfibro 267 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Pulfibro 801 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Pulfibro 534 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Pulmosis 801 mg (Tablet) - incepta-pharmaceuticals-ltd